CAS: 195611-82-6

GW7604 is an antiestrogen and it also is the metabolite of GW5638. GW5638 is an antagonist of high-affinity estrogen receptor (ER).

GW7604 is a potent chemical inhibitor, which is developed from synthetic organic compounds with highly specific mechanisms of action. Its primary mode of action involves the inhibition of certain protein kinases that are overexpressed in particular tumor cells. Consequently, this inhibition disrupts signaling pathways that are vital for cancer cell proliferation and survival. GW7604 is predominantly utilized in oncological research to dissect the molecular pathways involved in cancer progression and to explore its potential role in therapeutic strategies. By targeting aberrant kinase activity in tumor cells, GW7604 provides researchers with insight into the biochemical networks that sustain malignant growth. Its application extends to laboratory studies aiming to elucidate the underlying mechanisms of kinase-driven cancers, making it a valuable tool for identifying new therapeutic targets and evaluating drug efficacy.